Megestrol treatment in patients with hepatocellular carcinoma

por Farinati, F, Gianni, S, Giorgio, M De, Fiorentini, S
Publicado 2001

Octreotide and hepatocellular carcinoma

por Farinati, F, Sergio, A, Baldan, A, Zucchetta, P, Corleto, V D
Publicado 2007

High levels of transaminases at admission predict a severe disease course in COVID-19 hospitalized patients

por Pelizzaro, F., Kitenge, M.P., Maran, F., Cocconcelli, E., Balestro, E., Spagnolo, P., Cattelan, A., Farinati, F.
Publicado 2021

OC.04.1 HIGH LEVELS OF TRANSAMINASES AT ADMISSION PREDICT A SEVERE DISEASE COURSE IN COVID-19 HOSPITALIZED PATIENTS

por Pelizzaro, F., Kitenge, M.P., Maran, F., Cocconcelli, E., Balestro, E., Spagnolo, P., Cattelan, A., Farinati, F.
Publicado 2021

A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis

por Biselli, M, Conti, F, Gramenzi, A, Frigerio, M, Cucchetti, A, Fatti, G, D'Angelo, M, Dall'Agata, M, Giannini, E G, Farinati, F, Ciccarese, F, Andreone, P, Bernardi, M, Trevisani, F
Publicado 2015